top of page

TRANSVAC2, a success story!

Updated: Aug 23, 2019

The TRANSVAC2 success story has been published online on European Commission website.

© Kadmy, #94355258, 2018. source: via

To date, 80 % of all vaccines have been produced in Europe. TRANSVAC2 will create the network necessary to ensure Europe maintains and expands its international competitive edge.

This will be achieved by optimising the workflow for vaccine development through European universities, research institutes, innovative start-ups and large biomedical enterprises.


bottom of page